Third-look contrast-enhanced ultrasonography plus needle biopsy for differential diagnosis of magnetic resonance imaging-only detected breast lesions

Miyake, Tomohiro; Shimazu, Kenzo

Journal of Medical Ultrasonics, 2023

Number of Access:400（2025-12-12 00:39 Counts）

Identifier to cite or link to this item: https://hdl.handle.net/11094/90704

Link to primary information 

File Format Terms of use Size Views Date.Available Description information
JMU_30_2773 pdf None 289 KB 62 2024.03.11  

Item Information

Output File Export EndNote Basic Export Mendeley

Title
Third-look contrast-enhanced ultrasonography plus needle biopsy for differential diagnosis of magnetic resonance imaging-only detected breast lesions
Creator
NRID
1000000636110 1000000636110
ORCID
0000-0002-9362-9822 0000-0002-9362-9822
researchmap permalink
tomohiromiyake tomohiromiyake
Scopus Author ID
55165894400 55165894400
CreatorName
Miyake, Tomohiro
NRID
1000030448039 1000030448039
researchmap permalink
_-23f _-23f
Scopus Author ID
7005224756 7005224756
CreatorName
Shimazu, Kenzo
Subject
Breast cancer
MRI-only detected breast lesions
Contrast-enhanced ultrasonography
Second-look ultrasonography
Needle biopsy
Description
This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1007/s10396-023-01298-8.
Abstract
Research has shown that in approximately 20–30% of cases, breast lesions that were not detected on mammography (MG) or ultrasonography (US) were incidentally found during preoperative magnetic resonance imaging (MRI) examination for breast cancer. MRI-guided needle biopsy is recommended or considered for such MRI-only detected breast lesions invisible on second-look US, but many facilities in Japan cannot perform this biopsy procedure because it is expensive and time consuming. Thus, a simpler and more accessible diagnostic method is needed. Two studies to date have shown that third-look contrast-enhanced US (CEUS) plus needle biopsy for MRI-only detected breast lesions (i.e., MRI + /MG-/US-) that were not detected on second-look US showed moderate/high sensitivity (57.1 and 90.9%) and high specificity (100.0% in both studies) with no severe complications. In addition, the identification rate was higher for MRI-only lesions with a higher MRI BI-RADS category (i.e., category 4/5) than for those with a lower category (i.e., category 3). Despite the fact that there are limitations in our literature review, CEUS plus needle biopsy is a feasible and convenient diagnostic tool for MRI-only lesions invisible on second-look US and is expected to reduce the frequency of MRI-guided needle biopsy. When third-look CEUS does not reveal MRI-only lesions, a further indication for MRI-guided needle biopsy should be considered according to the BI-RADS category.
Publisher
Springer
Source Title
Journal of Medical Ultrasonics
Date of Issued
2023-03-11
Handle URL
https://hdl.handle.net/11094/90704
PISSN
13464523
eISSN
16132254
NCID
AA11563281
Relation.isVersionOf
DOI (Publisher Version)
https://doi.org/10.1007/s10396-023-01298-8
Access Rights
open access
oaire:version
Accepted Manuscript
Category
学術雑誌論文 Journal Article